KOPRAN. Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KOPRAN. Quarterly Results    (KPRL)

Here are the latest quarterly results of KOPRAN.. For more details, see the KOPRAN. financial fact sheet and KOPRAN. share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

KOPRAN. Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-19
*
3
Sep-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m8418788741,2091,1901,1211,399753 
Other income Rs m251423556424728 
Turnover Rs m8668928761,2441,2451,1631,446782 
Expenses Rs m7667717591,0089789091,205660 
Gross profit Rs m7610710920121221119393 
Depreciation Rs m2325242526252627 
Interest Rs m2120221914171211 
Profit before tax Rs m56766519222721120283 
Tax Rs m1420165061545220 
Profit after tax Rs m42574814216615715064 
Gross profit margin %9.012.112.516.617.818.813.812.3 
Effective tax rate %25.225.825.526.026.825.725.723.8 
Net profit margin %5.06.55.511.814.014.010.88.4 
Diluted EPS Rs 1.0 1.3 1.1 3.3 3.8 3.6 3.5 1.5  
Diluted EPS (TTM) Rs NA NA 5.2 6.7 9.6 11.9 14.2 12.4  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Pharmaceuticals Company Quarterly Results:   LYKA LABS  JUBILANT PHARMOVA   DENIS CHEM LAB  NURECA  JENBURKT PH.  

Compare KOPRAN. With:   LYKA LABS  JUBILANT PHARMOVA   DENIS CHEM LAB  NURECA  JENBURKT PH.  



Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KOPRAN. SHARE PRICE


Sep 17, 2021 (Close)

TRACK KOPRAN.

  • Track your investment in KOPRAN. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KOPRAN.

KOPRAN. - TEVA PHARMA COMPARISON

COMPARE KOPRAN. WITH

MARKET STATS